SCHEMBL14811237

SCHEMBL14811237

COc1ccc(-c2cccc3c2C(=O)C(=O)N3)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.50
MAPT P10636 4/20 0.49
TTR P02766 1/20 0.49
GAA P10253 1/20 0.49
LRRK2 Q5S007 1/20 0.49
TDP1 Q9NUW8 1/20 0.49
HDAC4 P56524 1/20 0.49
HDAC2 Q92769 1/20 0.49
HDAC8 Q9BY41 1/20 0.49
CHEK1 O14757 1/20 0.47
CES1 P23141 1/20 0.46
APP P05067 1/20 0.45
SNCA P37840 1/20 0.45
BACE1 P56817 1/20 0.45
TNKS2 Q9H2K2 1/20 0.44
TGM2 P21980 1/20 0.44
PTPN1 P18031 1/20 0.44
CCNE2 O96020 1/20 0.44
CDK4 P11802 1/20 0.44
CCND1 P24385 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9110123 0.80 MAOA (0.57) MAPTGAALRRK2TDP1HDAC4
SCHEMBL11202707 0.76 PDE3B (0.51) ALDH1A1MAPTLRRK2CES1TGM2
SCHEMBL7828465 0.76 TLK2 (0.63) LRRK2CHEK1MAP2K1
SCHEMBL7828461 0.76 TLK2 (0.63) LRRK2CHEK1MAP2K1
Hydrochloric Acid SCHEMBL11214501 0.75 PDE3B (0.50) ALDH1A1MAPTLRRK2CES1TGM2
SCHEMBL11121469 0.74 HDAC4 (0.58) ALDH1A1MAPTTDP1HDAC4HDAC2
SCHEMBL29002763 0.74 HDAC4 (0.58) ALDH1A1MAPTTDP1HDAC4HDAC2
SCHEMBL1480120 0.74 HDAC4 (0.58) ALDH1A1MAPTTDP1HDAC4HDAC2
SCHEMBL281586 0.74 CES1 (0.55) ALDH1A1MAPTTDP1CHEK1CES1
SCHEMBL30397534 0.74 CES1 (0.55) ALDH1A1MAPTTDP1CHEK1CES1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140378451-A1 Cannabinoid-2-Receptor Agonists ISIS INNOVATION LIMITED (GB) 2014-12-25 US disclosed
US-20140378451-A1 Cannabinoid-2-Receptor Agonists ISIS INNOVATION LIMITED (GB) 2014-12-25 US disclosed
US-20140378451-A1 Cannabinoid-2-Receptor Agonists ISIS INNOVATION LIMITED (GB) 2014-12-25 US disclosed
EP-2766022-A1 CANNABINOID-2-RECEPTOR AGONISTS Isis Innovation Limited (GB) 2014-08-20 EP disclosed
WO-2013041859-A1 CANNABINOID-2-RECEPTOR AGONISTS ISIS INNOVATION LIMITED (GB) 2013-03-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140378451-A1 Cannabinoid-2-Receptor Agonists CNR2, CNR1, GPR18 ALDH1A1 3689/4885MAPT 2084/4885TTR 4610/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.